MedSkin Solutions Dr. Suwelack AG, based in Billerbeck, develops, manufactures, and distributes medical and cosmetic products based on refined biomaterials. Founded in 1997, the company utilizes proprietary processes such as the "Advanced CryoSafe" and "Captivation" methods to create highly functional solutions for wound care and skin care. With 153 employees, the company maintains subsidiaries in the USA and Japan as well as a liaison office in India. MDS AG positions itself as a specialized provider that distributes its products globally while meeting international quality standards such as ISO 13485 and MDSAP.
die Herstellung und der Vertrieb von kosmetischen, pharmazeutischen und Health Care Produkten. Die Gesellschaft kann zu diesem Zweck auch andere Unternehmen gründen, erwerben und sich an ihnen beteiligen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Coesfeld Local Court, HRB 2366 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Diana Ferro | Vorstand | Hamburg |
Source: German Commercial Register (Handelsregister) Coesfeld Local Court, HRB 2366 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | Rohergebnis€33.5M2 | €5,202,389 | €53,327,662 | — |
| 2024 | Rohergebnis€34.6M2 | €7,178,762 | €50,761,452 | — |
| 2023 | Rohergebnis€28.9M2 | €3,691,690 | €46,006,771 | — |
| 2022 | Rohergebnis€25.3M2 | €1,996,121 | €45,371,576 | — |
| 2021 | Rohergebnis€22.3M2 | €2,836,339 | €45,667,543 | — |
| 2020 | Rohergebnis€16M2 | €382,834 | €40,882,551 | — |
| 2019 | Rohergebnis€20.9M2 | €2,630,048 | €41,661,688 | — |
| 2018 | €27,381,045 | €2,732,104 | €42,173,496 | — |
| 2017 | €25,812,275 | €2,306,478 | €41,537,397 | — |
| 2016 | €24,741,823 | €818,650 | €37,847,484 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Coesfeld Local Court, HRB 2366 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €11,709,592 | 84.8% |
| Depreciation | €2,084,403 | 15.1% |
| Interest & Similar | €21,512 | 0.2% |
